 |
|
Routine Imaging of Asymptomatic Melanoma Patients With Metastasis to Sentinel Lymph Nodes Rarely Identifies Systemic Disease
Edward P. Miranda, MD;
Michael Gertner, MD;
James Wall, MD;
Elizabeth Grace, BA;
Mohammed Kashani-Sabet, MD;
Robert Allen, MD;
Stanley P. L. Leong, MD
Arch Surg. 2004;139:831-837.
Hypothesis The diagnostic yield of chest radiography; computed tomography (CT) of the chest, abdomen, and pelvis; and CT or magnetic resonance imaging of the brain in the initial evaluation of melanoma with metastasis to sentinel lymph nodes may not identify systemic disease.
Design Retrospective analysis.
Setting Tertiary care referral center.
Patients Of 1183 patients identified from a database of individuals who underwent selective sentinel lymphadenectomy for primary melanoma (Breslow thickness, 0.2-30 mm), we studied 185 with at least 1 sentinel lymph node positive for metastatic melanoma (Breslow thickness, 0.8-14.5 mm).
Interventions Chest radiography; CT of the chest, abdomen, and pelvis; and CT or magnetic resonance imaging of the brain after selective sentinel lymphadenectomy with positive sentinel lymph nodes. The medical records of the 185 patients were systematically reviewed by 4 physician reviewers, and data were extracted primarily from pathology and radiology reports. When medical records were unavailable, information was taken from formal clinic and inpatient progress notes.
Main Outcome Measure Diagnostic yield of imaging studies.
Results The results of 0.5% of the imaging studies were positive for metastatic disease, 86% were negative, and 14% were indeterminate. Indeterminate results were confirmed to be negative by additional studies ranging from repeated imaging to invasive procedures, including thoracotomy and brain biopsy. The yields are as follows: chest radiography, 0%; chest CT, 0.7%; abdominal and pelvic CT, 0.7%; brain CT, 0%; and brain magnetic resonance imaging, 0%. Only 1 patient (0.5%) had detectable metastatic disease, and he had symptoms of systemic disease at the time of imaging.
Conclusions Computed tomography of the chest, abdomen and pelvis, and brain rarely reveals systemic metastasis at the time of selective sentinel lymphadenectomy. Routine imaging of asymptomatic patients at the time of selective sentinel lymphadenectomy is not indicated.
From the Departments of Surgery (Drs Miranda, Gertner, Wall, Allen, and Leong and Ms Grace) and Dermatology (Dr Kashani-Sabet) and the UCSF Melanoma Center (Drs Kashani-Sabet, Allen, and Leong), University of California San Francisco.
RELATED LETTER
Futility of Positron Emission Tomography and Other Modalities in the Initial Radiographic Screening of Patients With Melanoma
Edward P. Miranda
Arch Surg. 2006;141(10):1050.
EXTRACT
| FULL TEXT
RELATED ARTICLE
This Month in Archives of Surgery
Arch Surg. 2004;139(8):813.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Yield and Predictors of Radiologic Studies for Identifying Distant Metastases in Melanoma Patients with a Positive Sentinel Lymph Node Biopsy
Gold et al.
Ann. Surg. Oncol. 2007;14:2133-2140.
ABSTRACT
| FULL TEXT
In Reply
Aloia and Mansfield
JCO 2006;24:5178-5178.
FULL TEXT
Futility of Positron Emission Tomography and Other Modalities in the Initial Radiographic Screening of Patients With Melanoma
Miranda
Arch Surg 2006;141:1050-1050.
FULL TEXT
Utility of Computed Tomography and Magnetic Resonance Imaging Staging Before Completion Lymphadenectomy in Patients With Sentinel Lymph Node-Positive Melanoma
Aloia et al.
JCO 2006;24:2858-2865.
ABSTRACT
| FULL TEXT
Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma
Belhocine et al.
JNM 2006;47:957-967.
ABSTRACT
| FULL TEXT
Futility of fluorodeoxyglucose f 18 positron emission tomography in initial evaluation of patients with t2 to t4 melanoma.
Clark et al.
Arch Surg 2006;141:284-288.
ABSTRACT
| FULL TEXT
Management of Cutaneous Melanoma
de Giorgi et al.
NEJM 2004;351:2770-2771.
FULL TEXT
|
